1. Magri, D, Piepoli, M, Corrà, U, et al. Cardiovascular death risk in recovered mid-range ejection fraction heart failure: Insights from cardiopulmonary exercise test. J Card Fail. Epub ahead of print 17 May 2020. DOI:10.1016/j.cardfail.2020.04.021.
Google Scholar | Crossref | Medline2. Aaronson, KD, Schwartz, JS, Chen, TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660–2667.
Google Scholar | Crossref | Medline | ISI3. Levy, WC, Mozaffarian, D, Linker, DT, et al. The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation 2006; 113: 1424–1433.
Google Scholar | Crossref | Medline | ISI4. Agostoni, P, Paolillo, S, Mapelli, M, et al. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison. Eur J Heart Fail 2018; 20: 700–710.
Google Scholar | Crossref | Medline5. Kouwert, IJ, Bakker, EA, Cramer, MJ, et al. Comparison of MAGGIC and MECKI risk scores to predict mortality after cardiac rehabilitation among Dutch heart failure patients. Eur J Prev Cardiol. Epub ahead of print 26 July 2019. DOI: 10.1177/2047487319865730.
Google Scholar6. Agostoni, P, Corrà, U, Cattadori, G, et al.; MECKI Score Research Group. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. Int J Cardiol 2013; 167: 2710–2718.
Google Scholar | Crossref | Medline | ISI7. Corrà, U, Agostoni, P, Giordano, A, et al. The Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study. Int J Cardiol 2016; 203: 1067–1072.
Google Scholar | Crossref | Medline | ISI8. Paolillo, S, Veglia, F, Salvioni, E, et al. Heart failure prognosis over time: How the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years. Eur J Heart Fail 2019; 21: 208–217.
Google Scholar | Crossref | Medline9. Mapelli, M, Salvioni, E, de Martino, F, et al. Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction [published online J Cardiovasc Med (Hagerstown). Epub ahead of print, 17 July 2020. DOI: 10.2459/JCM.0000000000001018.
Google Scholar10. Vignati, C, Morosin, M, Fusini, L, et al. Do rebreathing manoeuvres for non-invasive measurement of cardiac output during maximum exercise test alter the main cardiopulmonary parameters? Eur J Prev Cardiol 2019; 26: 1616–1622.
Google Scholar | SAGE Journals | ISI11. Carriere, C, Corrà, U, Piepoli, MF. Isocapnic buffering period: From physiology to clinics. Eur J Prev Cardiol 2019; 26: 1107–1114.
Google Scholar | SAGE Journals | ISI12. Corra, U, Giordano, A, Bosimini, E, et al. Oscillatory ventilation during exercise in patients with chronic heart failure: Clinical correlates and prognostic implications. Chest 2002; 121: 1572–1580.
Google Scholar | Crossref | Medline | ISI13. Piepoli, MF, Ponikowski, PP, Volterrani, M, et al. Aetiology and pathophysiological implications of oscillatory ventilation at rest and during exercise in CHF: Do Cheyne and Stokes have an important message for modern-day patients with heart failure? Eur Heart J 1999; 20: 946–953.
Google Scholar | Crossref | Medline | ISI14. Stewart Coats, AJ, Shewan, LG, Abraham, WT. The management of co-morbidities in patients with heart failure: Central sleep apnoea. Int Cardiovasc Forum J 2015; 2: 2.
Google Scholar15. Vitale, C, Jankowska, E, Hill, L, et al. Heart Failure Association/European Society of Cardiology position paper on frailty in patients with heart failure. Eur J Heart Fail 2019; 21: 1299–1305.
Google Scholar | Crossref | Medline16. Ponikowski, P, Piepoli, M, Chua, TP, et al. The impact of cachexia on cardiorespiratory reflex control in chronic heart failure. Eur Heart J 1999; 20: 1667–1675.
Google Scholar | Crossref | Medline | ISI